Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.85    0.10 (3.64%)
Bid:
2.75
Ask:
2.85
Spread: 0.10 (3.636%)
Market Cap: £5.20m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Material Development and Supply Agreement

8 Feb 2018 07:00

RNS Number : 2474E
Nanoco Group PLC
08 February 2018
 

This announcement contains inside information as defined in EU Regulation No. 596/2014 and is in accordance with the Company's obligations under Article 17 of that Regulation.

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Material Development and Supply Agreement

 

New partnership includes infrastructure investment, development, milestones and commercial supply agreement

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and nanomaterials, announces that it has signed a Material Development and Supply Agreement with a large, undisclosed US listed corporation (the "Partner").

 

Under this agreement, Nanoco will scale-up and mass produce novel nano-particles for advanced electronic devices and supply them from its state-of-the-art production facility in Runcorn, UK. In preparation for the quantity of materials needed for these markets, the Partner will fund the capital expenditure required to expand Nanoco's Runcorn facility. The commercial terms of the agreement include payments for success based milestones, and commercial supply of materials, both of which will strengthen Nanoco's balance sheet. Based on the current timelines, commercial supply is anticipated to begin early 2019.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"This transaction not only exemplifies the potential of our technology, but also the recognition that Nanoco can continue to pursue broad partnerships in diverse markets.

 

Our deep expertise in the development and mass production of highly differentiated nanoparticles has enabled us to create partnerships, and future revenue streams, with partners around the globe. We are very pleased to announce today's agreement, and we look forward to updating you on our progress."

 

For further information, please contact:

 

Nanoco Group PLC Tel: +44 7788 897 357

Caroline Watson, Investor Relations Manager

Cwatson@nanocotechnologies.com

  

MHP Communications Tel: +44 (0) 20 3128 8570

Reg Hoare / Andrew Leach / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

The person responsible for arranging for the release of this announcement on behalf of the Company is David Blain, Chief Financial Officer.

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTZMGGZRNZGRZM
Date   Source Headline
13th Jun 20147:00 amRNSHolding(s) in Company
9th Jun 201412:30 pmRNSReceives TSB Grant for Bio-imaging
29th May 20147:00 amRNSPresentation at Display Week 2014
28th May 20141:41 pmRNSHolding(s) in Company
27th May 20145:21 pmRNSHolding(s) in Company
23rd May 20144:45 pmRNSHolding(s) in Company
15th May 20142:22 pmRNSHolding(s) in Company
13th May 20147:00 amRNSHolding(s) in Company
7th May 20143:45 pmRNSHolding(s) in Company
2nd May 20146:03 pmRNSHolding(s) in Company
2nd May 20143:37 pmRNSHolding(s) in Company
29th Apr 20142:25 pmRNSHolding(s) in Company
29th Apr 201411:58 amRNSHolding(s) in Company
24th Apr 20147:00 amRNSWelcomes RoHS Report
17th Apr 20143:48 pmRNSHolding(s) in Company
9th Apr 20149:00 amRNSHolding(s) in Company
4th Apr 20141:30 pmRNSHolding(s) in Company
1st Apr 20146:23 pmRNSHolding(s) in Company
28th Mar 201410:45 amRNSHolding(s) in Company
25th Mar 20147:00 amRNSInterim Results
14th Mar 20149:14 amRNSHolding(s) in Company
5th Mar 20149:30 amRNSHolding(s) in Company
28th Feb 20143:10 pmRNSHolding(s) in Company
14th Feb 201412:04 pmRNSHolding(s) in Company
12th Feb 20149:49 amRNSHolding(s) in Company
10th Feb 20149:01 amRNSHolding(s) in Company
7th Feb 20149:44 amRNSHolding(s) in Company
4th Feb 20147:00 amRNSHolding(s) in Company
30th Jan 20147:00 amRNSNotification of Interim Results
27th Jan 201411:45 amRNSHolding(s) in Company
24th Jan 20147:00 amRNSDirector's Dealing
22nd Jan 201412:30 pmRNSHolding(s) in Company
21st Jan 201411:10 amRNSHolding(s) in Company
21st Jan 20148:55 amRNSDirector's Dealing
20th Jan 201410:06 amRNSHolding(s) in Company
18th Dec 201311:15 amRNSResult of AGM
18th Dec 20137:00 amRNSAGM Statement
12th Dec 201311:19 amRNSBlocklisting Interim Review
13th Nov 20138:50 amRNSHolding(s) in Company
12th Nov 20137:00 amRNSPosting of Annual Report & Accounts
5th Nov 201312:09 pmRNSHolding(s) in Company
29th Oct 201311:56 amRNSHolding(s) in Company
21st Oct 20133:45 pmRNSHolding(s) in Company
17th Oct 20134:34 pmRNSHolding(s) in Company
17th Oct 20134:33 pmRNSChange of significant shareholder ownership
17th Oct 20134:33 pmRNSHolding(s) in Company
17th Oct 20134:29 pmRNSHolding(s) in Company
15th Oct 20135:21 pmRNSHolding(s) in Company
15th Oct 20135:14 pmRNSHolding(s) in Company
15th Oct 20134:00 pmRNSCompletion of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.